US Stocks
/
Larimar Therapeutics, Inc. Share Price
Larimar Therapeutics, Inc. Share Price

Larimar Therapeutics, Inc. Share Price

NASDAQ: LRMR | Micro Cap
$3.78
-$0.04 (-1.05%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Larimar Therapeutics, Inc. Stock Performance

Open
$3.78
Prev. Close
$3.82
Circuit Range
N/A
Day Range
$3.75 - $3.88
Year Range
$2.72 - $6.42
Volume
1,39,449
Average Traded
$3.80

Larimar Therapeutics, Inc. Share Price Today

As of 20 September 2026, Larimar Therapeutics, Inc.'s share price is $3.78. The stock opened at $3.78, compared to its previous close of $3.82. During today's trading session, Larimar Therapeutics, Inc.'s share price traded between $3.75 and $3.88, with an average price of $3.82. Over the past 52 weeks, the stock has recorded a high of $6.42 and a low of $2.72. In terms of performance, Larimar Therapeutics, Inc.'s share price has declined by 16.00% over the last six months and is up 17.21% on a year-on-year basis.

Larimar Therapeutics, Inc. Share Price Chart

$3.75$3.88
L
Show Current Price
H

Larimar Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$945000.00
PE Ratio (TTM)
-3.18
Dividend Yield
N/A
EPS (TTM)
$-1.19
Revenue (TTM)
N/A
Return On Equity (TTM)
-212.17%
Profit Margin
N/A
Debt to Equity
0.83
Quarterly Earnings Growth YoY
-207.84%

Larimar Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$14.65M-$21.63M-$15.50M-$29.28M-$26.18M-$47.71M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-47.58%28.33%-88.92%10.58%-82.23%

Larimar Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$50.64M-$35.35M-$36.95M-$80.60M-$165.67M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A30.18%-4.51%-118.15%-105.54%

About Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Larimar Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$3.80
$3.77
-6.56%
Aug 2026
$3.81
$4.04
+5.62%
Jul 2026
$3.07
$3.83
+25.82%
Jun 2026
$3.45
$3.04
-12.77%
May 2026
$4.03
$3.48
-14.14%
Apr 2026
$4.62
$4.06
-9.80%
Mar 2026
$5.00
$4.50
-15.25%
Feb 2026
$3.48
$5.31
+50.42%
Jan 2026
$3.71
$3.53
-7.47%
Dec 2025
$3.41
$3.81
+7.46%
Nov 2025
$3.95
$3.55
-8.97%
Oct 2025
$3.18
$3.90
+20.93%

LRMR Share Price FAQs

What is Larimar Therapeutics, Inc. share price today?

chevron-up
Larimar Therapeutics, Inc. share price today is $3.78 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Larimar Therapeutics, Inc. stock?

chevron-up
The 52 week high of Larimar Therapeutics, Inc. stock is $6.42, while the 52 week low is $2.72 as of 19 Sep '26.

What is LRMR's market capitalisation today?

chevron-up
LRMR market capitalisation is $945000.00 as of September 20, 2026, at 10:44 pm IST.

What is LRMR's net income for the last quarter?

chevron-up
LRMR's net income for the last quarter is -0.05B USD.

What is the 5 year returns of LRMR?

chevron-up
The 5 year returns of LRMR is -67.22% as on 19 Sep '26.

What is the high & low stock price of LRMR today?

chevron-up
LRMR stock price hit a high of $3.88 and low of $3.75 as of 19 Sep '26.

Can I buy LRMR shares in India?

chevron-up
Yes. You can buy LRMR in India by opening an international trading account.